Work

Azithromycin: India's First Indigenous Antibiotic

Year: 2025

Type: article

Abstract: Introduction After three decades of research and hard work, India has achieved a significant milestone in pharmaceutical innovation with the development of Nafithromycin, the nation's first indigenous macrolide antibiotic aimed at tackling Antimicrobial Resistance (AMR). Its successful introduction represents a major leap in the fight against AMR, offering hope for treating multi-drug-resistant infections and saving lives worldwide. This remarkable achievement marks a pivotal moment in the fight against AMR, showcasing India’s growing capabilities in pharmaceutical innovation.

Source: Zenodo (CERN European Organization for Nuclear Research)

DOI: 10.5281/zenodo.14860213

Author: Mimansha Sahu1 and Manish Kumar Baghel2

Language: English

Topic: Antibiotic Use and Resistance

Subfield: Applied Microbiology and Biotechnology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: green

OpenAlex ID: W6930468480

FWCI:

Cites:

Cited by:

Related to: